MegaMD Statistics

Total Valuation

MegaMD has a market cap or net worth of KRW 47.68 billion. The enterprise value is 16.70 billion.

Market Cap	47.68B
Enterprise Value	16.70B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

MegaMD has 22.07 million shares outstanding.

Current Share Class	22.07M
Shares Outstanding	22.07M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.40%
Owned by Institutions (%)	4.23%
Float	10.55M

Valuation Ratios

The trailing PE ratio is 18.00.

PE Ratio	18.00
Forward PE	n/a
PS Ratio	1.32
PB Ratio	0.74
P/TBV Ratio	0.80
P/FCF Ratio	9.83
P/OCF Ratio	8.31
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.67, with an EV/FCF ratio of 3.44.

EV / Earnings	6.25
EV / Sales	0.46
EV / EBITDA	2.67
EV / EBIT	15.39
EV / FCF	3.44

Financial Position

The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.06.

Current Ratio	1.85
Quick Ratio	1.77
Debt / Equity	0.06
Debt / EBITDA	0.59
Debt / FCF	0.80
Interest Coverage	6.23

Financial Efficiency

Return on equity (ROE) is 4.19% and return on invested capital (ROIC) is 1.32%.

Return on Equity (ROE)	4.19%
Return on Assets (ROA)	1.03%
Return on Invested Capital (ROIC)	1.32%
Return on Capital Employed (ROCE)	2.15%
Revenue Per Employee	231.81M
Profits Per Employee	17.12M
Employee Count	156
Asset Turnover	0.42
Inventory Turnover	32.73

Taxes

In the past 12 months, MegaMD has paid 865.97 million in taxes.

Income Tax	865.97M
Effective Tax Rate	24.49%

Stock Price Statistics

The stock price has decreased by -5.29% in the last 52 weeks. The beta is 0.76, so MegaMD's price volatility has been lower than the market average.

Beta (5Y)	0.76
52-Week Price Change	-5.29%
50-Day Moving Average	2,308.10
200-Day Moving Average	2,179.35
Relative Strength Index (RSI)	41.76
Average Volume (20 Days)	148,456

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MegaMD had revenue of KRW 36.16 billion and earned 2.67 billion in profits. Earnings per share was 120.00.

Revenue	36.16B
Gross Profit	21.37B
Operating Income	1.43B
Pretax Income	3.54B
Net Income	2.67B
EBITDA	6.60B
EBIT	1.43B
Earnings Per Share (EPS)	120.00

Full Income Statement

Balance Sheet

The company has 34.85 billion in cash and 3.87 billion in debt, giving a net cash position of 30.99 billion or 1,403.63 per share.

Cash & Cash Equivalents	34.85B
Total Debt	3.87B
Net Cash	30.99B
Net Cash Per Share	1,403.63
Equity (Book Value)	64.26B
Book Value Per Share	2,910.82
Working Capital	17.74B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.74 billion and capital expenditures -885.14 million, giving a free cash flow of 4.85 billion.

Operating Cash Flow	5.74B
Capital Expenditures	-885.14M
Free Cash Flow	4.85B
FCF Per Share	219.71

Full Cash Flow Statement

Margins

Gross margin is 59.10%, with operating and profit margins of 3.95% and 7.38%.

Gross Margin	59.10%
Operating Margin	3.95%
Pretax Margin	9.78%
Profit Margin	7.38%
EBITDA Margin	18.24%
EBIT Margin	3.95%
FCF Margin	13.41%

Dividends & Yields

This stock pays an annual dividend of 60.00, which amounts to a dividend yield of 2.79%.

Dividend Per Share	60.00
Dividend Yield	2.79%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	2.83%
Earnings Yield	5.60%
FCF Yield	10.17%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MegaMD has an Altman Z-Score of 2.6 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.6
Piotroski F-Score	6